MindWalk Holdings Corp.
Key statistics
from XBRL data in SEC filingsAI briefing
from the latest 10-K, 10-Q and 8-K eventsMindWalk Holdings Corp. (formerly ImmunoPrecise Antibodies Ltd.) is a British Columbia-incorporated, Nasdaq-listed company with principal offices in Austin, Texas, as of the fiscal year ended April 30, 2026.
What they do
The filing identifies the company as MindWalk Holdings Corp., formerly ImmunoPrecise Antibodies Ltd., and its consolidated subsidiaries. It is registered with the SEC as a foreign private issuer incorporated in British Columbia, with common shares trading on Nasdaq under the symbol HYFT. Its SIC classification is Pharmaceutical Preparations. The excerpts provided do not describe the company's specific products or services.
Recent performance
The excerpts provided contain no income statement, revenue, loss, cash flow or balance sheet figures for the fiscal year ended April 30, 2026. No period-over-period comparisons are available in the source material. Accordingly, no performance assessment can be made from these excerpts.
Strategy
The excerpts provided do not include management's discussion of strategy, priorities or planned investments. The only directional item captured is the company's name change from ImmunoPrecise Antibodies Ltd. to MindWalk Holdings Corp. No further statements of direction can be supported by the source material.
Risks
- Foreign private issuer status — As a British Columbia corporation filing on Form 20-F, the company is subject to foreign private issuer reporting and governance requirements that differ from those for U.S. domestic filers.
- Emerging growth company status — The filing includes checkboxes for emerging growth company and non-accelerated filer status, which if applicable would exempt the company from certain disclosure and auditor attestation requirements.
- Nasdaq listing dependence — The company's common shares are registered under Section 12(b) and trade on the Nasdaq Stock Market under HYFT, making it subject to Nasdaq continued listing standards.
- Limited source disclosure — The provided excerpts contain no financial statements or risk factor text, so the company's specific operating, liquidity and regulatory risks cannot be assessed from this material.
Outlook
The excerpts provided do not include management's outlook, guidance or forward-looking operating targets. No forward-looking statements beyond the standard cautionary note referenced in the table of contents are available. No outlook can be stated from this source material.